Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report. Before that can happen though, the U.S. government needs to grant the company approval, which is far from certain. In 2022, the U.S. Food and Drug Administration rejected its application to proceed with human trials due to safety concerns. Neuralink has been working to address those concerns ever since.
Dr. Deena Gupta-Adimoolam, a primary care specialist, joined Cheddar News to talk about how people can prepare themselves for emergency hospital visits.
Dr. Natali Edmonds, a geropsychologist, joined Cheddar News to provide some tips on identifying early signs of dementia and to discuss home-care options.
